Growth Metrics

Q32 Bio (QTTB) Non-cash Items (2017 - 2026)

Q32 Bio's quarterly Non-cash Items came in at $1.2 million in Q1 2026, down 21.47% quarter-over-quarter from $1.6 million in Q4 2025.

Q32 Bio has reported Non-cash Items for 10 years, with the latest figure at $1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-cash Items changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $1.6 million, up 13058233.33% from the prior year.
  • Non-cash Items for Q1 2026 stood at $1.2 million, down from $1.6 million in the prior quarter.
  • The five-year high for Non-cash Items was $62.8 million in Q3 2024, with the low at $12.0 in Q4 2024.
  • Average Non-cash Items over 5 years is $7.0 million, with a median of $1.2 million recorded in 2026.
  • Peak annual rise in Non-cash Items reached 13058233.33% in 2025, while the deepest fall reached 99.99% in 2025.
  • Tracing QTTB's Non-cash Items over 5 years: stood at $493000.0 in 2022, then slumped by 97.83% to $10712.0 in 2023, then sank by 99.89% to $12.0 in 2024, then jumped by 13058233.33% to $1.6 million in 2025, then declined by 21.47% to $1.2 million in 2026.
  • The last three Non-cash Items figures came in at $1.2 million (Q1 2026), $1.6 million (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Q32 Bio 162.94 Mn 112.19 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.23 Mn
Mar 31, 2026 1.23 Mn
Dec 31, 2025 1.57 Mn
Dec 31, 2025 1.57 Mn
Sep 30, 2025 5,000.00
Sep 30, 2025 5,000.00
Dec 31, 2024 12.00
Dec 31, 2024 12.00
Sep 30, 2024 62.83 Mn
Sep 30, 2024 62.83 Mn
Jun 30, 2024 691,080.00
Jun 30, 2024 691,080.00
Mar 31, 2024 10.62 Mn
Mar 31, 2024 10.62 Mn
Dec 31, 2023 10,712.00
Dec 31, 2023 10,712.00
Sep 30, 2023 7.57 Mn
Sep 30, 2023 7.57 Mn
Jun 30, 2023 7.25 Mn
Jun 30, 2023 7.25 Mn
Mar 31, 2023 6.65 Mn
Mar 31, 2023 6.65 Mn
Dec 31, 2022 493,000.00
Dec 31, 2022 493,000.00
Sep 30, 2022 717,000.00
Sep 30, 2022 717,000.00
Jun 30, 2022 982,000.00
Jun 30, 2022 982,000.00
Mar 31, 2022 4.87 Mn
Mar 31, 2022 4.87 Mn
Dec 31, 2021 2.07 Mn
Dec 31, 2021 2.07 Mn
Sep 30, 2021 4.11 Mn
Sep 30, 2021 4.11 Mn
Jun 30, 2021 5.30 Mn
Jun 30, 2021 5.30 Mn
Mar 31, 2021 8.68 Mn
Mar 31, 2021 8.68 Mn
Dec 31, 2020 12.28 Mn
Dec 31, 2020 12.28 Mn
Sep 30, 2020 11.30 Mn
Sep 30, 2020 11.30 Mn
Jun 30, 2020 2.31 Mn
Jun 30, 2020 2.31 Mn
Mar 31, 2020 1.93 Mn
Mar 31, 2020 1.93 Mn
Dec 31, 2019 33.81 Mn
Dec 31, 2019 33.81 Mn
Sep 30, 2019 26.52 Mn
Sep 30, 2019 26.52 Mn
Jun 30, 2019 30.94 Mn
Jun 30, 2019 30.94 Mn
Mar 31, 2019 55.54 Mn
Mar 31, 2019 55.54 Mn
Dec 31, 2018 39.02 Mn
Dec 31, 2018 39.02 Mn
Sep 30, 2018 40.65 Mn
Sep 30, 2018 40.65 Mn
Jun 30, 2018 454,799.00
Jun 30, 2018 454,799.00
Mar 31, 2018 31.33 Mn
Mar 31, 2018 31.33 Mn
Dec 31, 2017 5.98 Mn
Dec 31, 2017 5.98 Mn